The Difference Between Cystatin C– and Creatinine-Based Estimated GFR and Incident Frailty: An Analysis of the Cardiovascular Health Study (CHS)
Authors:
- 16 July 2020
- journal article
- letter
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 76 (6) , 896-898
Abstract
No abstract availableFunding Information
- American Kidney Fund
This publication has 10 references indexed in Scilit:
- The Difference Between Cystatin C– and Creatinine-Based Estimated GFR and Associations With Frailty and Adverse Outcomes: A Cohort Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT)American Journal of Kidney Diseases, 2020
- Kidney Function Estimated From Cystatin C, But Not Creatinine, Is Related to Objective Tests of Physical Performance in Community-Dwelling Older AdultsThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2017
- Cystatin C and the Risk of Frailty and Mortality in Older MenThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2016
- Body Mass Index Trajectories in Relation to Change in Lean Mass and Physical Function: The Health, Aging and Body Composition StudyJournal of the American Geriatrics Society, 2015
- Cystatin C as a biomarker for estimating glomerular filtration rateCurrent Opinion in Nephrology and Hypertension, 2015
- Kidney Function and Prevalent and Incident FrailtyClinical Journal of the American Society of Nephrology, 2013
- Serum Concentration of Cystatin C and Risk of End-Stage Renal Disease in DiabetesDiabetes Care, 2012
- Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin CNew England Journal of Medicine, 2012
- Frailty in Older Adults: Evidence for a PhenotypeThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2001
- The cardiovascular health study: Design and rationaleAnnals of Epidemiology, 1991